Vitamin D Deficiency in Patients With Hypertension
Status:
Terminated
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the effects of Vitamin D replacement and the effects of an approved
medication for hypertension, aliskiren (Tekturna), in patients with high blood pressure who
have low levels of vitamin D in their blood. The study will compare the effects of vitamin D
or aliskiren alone and in combination on 24-hour blood pressure and biochemical parameters.
Phase:
Phase 4
Details
Lead Sponsor:
UConn Health
Collaborator:
Novartis
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins